Home » Authors » Mark Lawson

Articles by Mark Lawson

BresaGen Merging Operations Of Stem Cell Unit With CyThera

Dec. 2, 2003

Peptech Settles License Dispute Concerning Abbott Labs' Humira

Nov. 26, 2003

Peptech Settles License Dispute Concerning Abbott Labs' Humira

Nov. 26, 2003

Financing Jump In Third Quarter; Cryptome, Pharmaxis Price IPOs

Oct. 15, 2003

Financing Jump In Third Quarter; Cryptome, Pharmaxis Price IPOs

Oct. 15, 2003

Singapore Making Biotech Waves With Vast New Biopolis Facility

Sep. 3, 2003

Singapore Making Biotech Waves With Vast New Biopolis Facility

Sep. 3, 2003

BresaGen Moving Operations To U.S. For Better Biotech Climate

Aug. 20, 2003

BresaGen Moving Operations To U.S. For Better Biotech Climate

Aug. 20, 2003

Australian Firm Defends Fees For Access To Noncoding DNA

July 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...